يعرض 1 - 20 نتائج من 269 نتيجة بحث عن '(((( cloud ((mean decrease) OR (a decrease)) ) OR ( _ parp decrease ))) OR ( via large decrease ))', وقت الاستعلام: 0.48s تنقيح النتائج
  1. 1

    HDECO: A method for Decreasing energy and cost by using virtual machine migration by considering hybrid parameters حسب Arash GhorbanniaDelavar (22563696)

    منشور في 2025
    "…<h2>Summary</h2><p dir="ltr">This research introduces <b>HDECO</b> (Hybrid Decreasing Energy and Cost Optimization) — a method designed to reduce both energy consumption and execution cost in cloud datacenters through intelligent virtual machine migration. …"
  2. 2

    Point cloud fusion instance effect. حسب Hongliang Zou (20707270)

    منشور في 2025
    "…<div><p>The study proposes a multi-sensor localization and real-timeble mapping method based on the fusion of 3D LiDAR point clouds and visual-inertial data, which addresses the issue of decreased localization accuracy and mapping in complex environments that affect the autonomous navigation of robot dogs. …"
  3. 3

    Inotodiol decreases clone formation in HCC cells. حسب Yushuang Xing (20636685)

    منشور في 2025
    "…In addition, inotodiol showed to induce apoptosis, characterized by an increase in Bax expression, a decrease in Bcl-2, Bcl-XL and MCL1 expression, the initiation of cleaved PARP1 and cleaved caspase 3, and inhibition of the MAPK/ERK pathway. …"
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    PARP9 knockdown promotes apoptosis and DNA damage. حسب Yating Li (1819822)

    منشور في 2024
    "…(E) DNA damage in GC cells significantly increased post-PARP9 knockdown as determined by comet assay. (F) The anti-DNA damage capacity of GC cells decreased markedly following reduction of PARP9 expression. …"
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Data Sheet 1_Imaging-based assessment of response to olaparib in platinum-sensitive relapsed ovarian cancer patients.pdf حسب Maria Delgado-Ortet (8840702)

    منشور في 2025
    "…In this work, we developed noninvasive imagingbased measurements of spatial and longitudinal heterogeneity in a retrospective analysis of a phase 2 non-randomized study of germline BRCA1/BRCA2 mutated (gBRCAm) ovarian cancer patients treated with combination of PARP inhibitors (PARPi) and immune checkpoint inhibitors (ICIs).…"